National Center for Advancing Translational Sciences; Notice of Closed Meetings, 104197-104198 [2024-30324]

Download as PDF Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: December 16, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. Dated: December 16, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS–NIH–CDC–SBIR PHS 2025–1 Phase I and Phase II: Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models (Topic 141). Date: January 14–16, 2025. Time: 10:30 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G56, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Poonam Tewary, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G56, Rockville, MD 20892, (301) 761–7219, tewaryp@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) [FR Doc. 2024–30327 Filed 12–19–24; 8:45 am] [FR Doc. 2024–30363 Filed 12–19–24; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center For Scientific Review; Notice of Closed Meetings National Center for Advancing Translational Sciences; Notice of Closed Meetings Dated: December 16, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–30360 Filed 12–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting ddrumheller on DSK120RN23PROD with NOTICES1 104197 Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, Informatics Technologies for Cancer Research, January 29, 2025, 10 a.m. to January 29, 2025, 6 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W106, Rockville, Maryland, 20850 which was published in the Federal Register on November 27, 2024, FR Doc 2024– 27877, 89 FR 93623. This notice is being amended to change the meeting date and time from January 29, 2025, 10 a.m. to 6 p.m. to February 6, 2025, 10 a.m. to 6 p.m. and February 7, 2025, 10 a.m. to 2 p.m. The meeting format and location will stay the same. The meeting is closed to the public. VerDate Sep<11>2014 20:12 Dec 19, 2024 Jkt 265001 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Drug Development. Date: January 7, 2025. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Maureen Shuh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–4097, maureen.shuh@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Immunology and Infectious Diseases. Date: January 14, 2025. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anthony David Foster, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–3297, anthony.foster@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00126 Fmt 4703 Sfmt 4703 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Topic 025: Benchtop Device to Perform Batch Evaporation. Date: January 27, 2025. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Rockville, MD 20892 (Virtual). Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Suite 1E504, Rockville, MD 20892, (301) 594–7319, rahat.khan@nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Topic 026: Liver and Brain Organoids Derived from Human iPS Cells. Date: January 29, 2025. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Rockville, MD 20892 (Virtual). Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Suite 1E504, Rockville, MD 20892, (301) 594–7319, rahat.khan@nih.gov. E:\FR\FM\20DEN1.SGM 20DEN1 104198 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: December 16, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–30324 Filed 12–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7080–N–60] 30-Day Notice of Proposed Information Collection: Requirements for Designating Housing Projects; OMB Control No.: 2577–0192 Office of Policy Development and Research, Chief Data Officer, HUD. ACTION: Notice. AGENCY: HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comment from all interested parties on the proposed collection of information. The purpose of this notice is to allow for an additional 30 days of public comment. DATES: Comments Due Date: January 21, 2025. ADDRESSES: Interested persons are invited to submit comments regarding this proposal. Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Interested persons are also invited to submit comments regarding this proposal by name and/or OMB Control Number and should be sent to: Anna Guido, Clearance Officer, REE, Department of Housing and Urban Development, 451 7th Street SW, Room 8210, Washington, DC 20410–5000; telephone 202–402–5534 (this is not a toll-free number). FOR FURTHER INFORMATION CONTACT: Anna Guido, Clearance Officer, REE, ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: 1 Ziprecruiter.com, available at https:// www.ziprecruiter.com/Salaries/Public-HousingAuthority-Salary. VerDate Sep<11>2014 20:12 Dec 19, 2024 Jkt 265001 Department of Housing and Urban Development, 451 7th Street SW, Washington, DC 20410; email Anna.P.Guido@hud.gov, telephone 202– 402–5534. This is not a toll-free number. HUD welcomes and is prepared to receive calls from individuals who are deaf or hard of hearing, as well as individuals with speech or communication disabilities. To learn more about how to make an accessible telephone call, please visit https:// www.fcc.gov/consumers/guides/ telecommunications-relay-service-trs. Copies of available documents submitted to OMB may be obtained from Ms. Guido. SUPPLEMENTARY INFORMATION: This notice informs the public that HUD is seeking approval from OMB for the information collection described in Section A. The Federal Register notice that solicited public comment on the information collection for a period of 60 days was published on September 18, 2024 at 89 FR 76498. This notice informs the public that HUD is seeking approval from OMB for the information collection described in Section A. A. Overview of Information Collection Title of Information Collection: Requirements for Designating Housing Projects. OMB Approval Number: 2577–0192. Type of Request: Revision of currently approved collection. Form Number: None. Description of the need for the information and proposed use: The information collection burden associated with designated housing is required by statute. Section 10 of the Housing Opportunity and Extension Act of 1996 modified Section 7 of the U.S. Housing Act of 1937 to require Public Housing Agencies (PHAs) to submit a plan for HUD approval before a project(s) can be designated as either elderly only, disabled only, or elderly and disabled. In this plan, PHAs must document why the designation is needed and provide the following information: 1. Description of the designated housing plan; 2. Justification for the designation; 3. Availability of alternative housing resources for the non-designated population(s); 2 Computed Hourly Rates of Pay Using the 2,087Hour Divisor, available at https://www.opm.gov/ policy-data-oversight/pay-leave/pay- PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 4. Impact on the availability of accessible housing; 5. A statement that existing tenants in good standing will not be evicted; 6. A statement of the resources that will be made available if the PHA offers voluntary relocation benefits; and 7. Information describing how the DHP is consistent with any outstanding court orders, lawsuits, investigations, Voluntary Compliance Agreements (VCAs), Conciliation Agreements, or Letters of Findings or Determinations, etc., including for example, actions under Title VI of the Civil Rights Act, Section 504 of the Rehabilitation Act, the Age Discrimination Act, the Fair Housing Act, or the Americans with Disabilities Act. Respondents (i.e. affected public): State, or Local Government. Estimated Number of Respondents: 21 for New and Amendment DHPs and 22 for DHP Renewals. Estimated Number of Responses: 1 per request. Frequency of Response: As needed for New/Amendment DHPs and every two years for renewals. Average Hours per Response: 15 hours for New and Amendment DHPs and 3 hours for DHP Renewals. Total Estimated Burdens: 315 hours for New and Amendment DHPs and 66 for DHP Renewals. The previous estimation of 270 annual burden hours has been increased to 315 for New and Amendment DHPs and 66 for DHP Renewals. This change is based on the average number of Plans submitted between Calendar Years 2022 and 2023. In FY22 and FY23, several Public Housing Authorities (PHAs) failed to renew their DHP in a timely manner, leading to a slight uptick in the number of respondents, as these PHAs were required to submit new plans for approval. Furthermore, HUD anticipates a continued decline in the number of respondents due to the ongoing trend in PHAs repositioning their developments and exiting the public housing program. The national average PHA staff salary = $64,590 1 per year or $31.00 per hour. The calculation for costs is as follows: • New and Amendment DHPs: 21 PHAs × 15 hours = 315 hours × $31 2 = $9,765. • DHP Renewals: 22 PHAs × 3 hours = 66 hours × $31 = $2,046. administration/fact-sheets/computing-hourly-ratesof-pay-using-the-2087-hour-divisor/. E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104197-104198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30324]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; Topic 025: Benchtop Device to 
Perform Batch Evaporation.
    Date: January 27, 2025.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Center for Advancing Translational Sciences, 
National Institutes of Health, 9609 Medical Center Drive, Rockville, 
MD 20892 (Virtual).
    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Center for Advancing 
Translational Sciences, National Institutes of Health, 9609 Medical 
Center Drive, Suite 1E504, Rockville, MD 20892, (301) 594-7319, 
[email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; Topic 026: Liver and Brain 
Organoids Derived from Human iPS Cells.
    Date: January 29, 2025.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Center for Advancing Translational Sciences, 
National Institutes of Health, 9609 Medical Center Drive, Rockville, 
MD 20892 (Virtual).
    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Center for Advancing 
Translational Sciences, National Institutes of Health, 9609 Medical 
Center Drive, Suite 1E504, Rockville, MD 20892, (301) 594-7319, 
[email protected].


[[Page 104198]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-30324 Filed 12-19-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.